Literature DB >> 29729355

Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.

Mallika Somayajulu1, Denise A Bessert2, Maik Hüttemann3, Jasloveleen Sohi4, John Kamholz5, Robert P Skoff6.   

Abstract

Proteolipid protein (PLP), besides its adhesive role in myelin, has been postulated to have multiple cellular functions. One well-documented function of PLP is regulation of oligodendrocyte (Olg) apoptosis. In contrast, DM20, an alternatively spliced product of the PLP1/Plp1 gene, has been proposed to have functions that are unique from PLP but these functions have never been elucidated. Here, we compare metabolism of PLP and DM20, and show that oxidative phosphorylation (OxPhos) was significantly decreased in Plp1 but not DM20 or EGFP expressing cells. The reserve OxPhos capacity of Plp1 expressing cells was half of control cells, suggesting that they are very vulnerable to stress. ATP in media of Plp1 expressing cells is significantly increased more than two-fold compared to controls; markers of apoptosis are increased in cells over-expressing Plp1, indicating that abnormal metabolism of PLP is most likely the direct cause leading to Olg apoptosis. We hypothesize that abnormal metabolism, mediated by increased insertion of PLP into mitochondria, underlies demyelination in Pelizaeus-Merzbacher Disease (PMD) and in models of PMD. To understand why PLP and DM20 function differently, we mutated or deleted amino acids located in the PLP-specific region. All these mutations and deletions of the PLP-specific region prevented insertion of PLP into mitochondria. These findings demonstrate that the PLP-specific region is essential for PLP's import into mitochondria, and now offer an explanation for deciphering unique functions of PLP and DM20.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metabolism; Mitochondria; Myelin; Oligodendrocytes; Pelizaeus-Merzbacher Disease; Proteolipid protein

Mesh:

Substances:

Year:  2018        PMID: 29729355      PMCID: PMC5975245          DOI: 10.1016/j.neulet.2018.05.005

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  52 in total

Review 1.  Structure and function of proteolipids in myelin and non-myelin membranes.

Authors:  M B Lees; J D Sakura; V S Sapirstein; W Curatolo
Journal:  Biochim Biophys Acta       Date:  1979-08-20

2.  Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.

Authors:  M McLaughlin; S A Karim; P Montague; J A Barrie; D Kirkham; I R Griffiths; J M Edgar
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

3.  Proteolipid protein regulates the survival and differentiation of oligodendrocytes.

Authors:  X Yang; R P Skoff
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

4.  Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease.

Authors:  Ajit Singh Dhaunchak; David R Colman; Klaus-Armin Nave
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 5.  Mitochondria and the autophagy-inflammation-cell death axis in organismal aging.

Authors:  Douglas R Green; Lorenzo Galluzzi; Guido Kroemer
Journal:  Science       Date:  2011-08-26       Impact factor: 47.728

6.  Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes.

Authors:  G Helynck; B Luu; J L Nussbaum; D Picken; G Skalidis; E Trifilieff; A Van Dorsselaer; P Seta; R Sandeaux; C Gavach; F Heitz; D Simon; G Spach
Journal:  Eur J Biochem       Date:  1983-07-01

7.  Analyses of proteolipid protein mutants show levels of proteolipid protein regulate oligodendrocyte number and cell death in vitro and in vivo.

Authors:  R P Skoff; I Saluja; D Bessert; X Yang
Journal:  Neurochem Res       Date:  2004-11       Impact factor: 3.996

8.  Release of adenosine and ATP during ischemia and epilepsy.

Authors:  Nicholas Dale; Bruno G Frenguelli
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.

Authors:  Jeremy J Laukka; John Kamholz; Denise Bessert; Robert P Skoff
Journal:  Neurosci Lett       Date:  2016-05-17       Impact factor: 3.046

10.  Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain.

Authors:  Carrie L Tatar; Sunita Appikatla; Denise A Bessert; Ajaib S Paintlia; Inderjit Singh; Robert P Skoff
Journal:  ASN Neuro       Date:  2010-09-27       Impact factor: 4.146

View more
  2 in total

1.  The wmN1 Enhancer Region of the Mouse Myelin Proteolipid Protein Gene (mPlp1) is Indispensable for Expression of an mPlp1-lacZ Transgene in Both the CNS and PNS.

Authors:  Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

2.  Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients.

Authors:  Yan Chen; Zheng Zheng; Ainong Mei; Huan Huang; Fan Lin
Journal:  Clinics (Sao Paulo)       Date:  2021-05-17       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.